Scholars Central

Conference abstractPublished 29 Feb 2016

Single use technologies support large scale manufacturing of adult stem cells

Authors: Julie Murrell

EMD Millipore Corporation, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

As innovators move closer to clinical success, a gap in the ability to cost effectively manufacture cell therapies has been identified. To address this gap, we have demonstrated the use of single-use expansion and harvest systems that robustly expand and recover a variety of stem cells. An additional contributor to the system is the inclusion of high quality reagents that are animal origin free, lead to better yields and are supplied with a strong regulatory dossier. We will present data regarding ease of use, yield, viability and characterization for full solution expansion and harvest of manufactured cell therapies. Start to finish solutions for expansion and harvest are key enabling technologies for success in commercializing cell therapies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectEngineering
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Julie Murrell”